Literature DB >> 29419435

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.

Sameer A Parikh1, Kari G Chaffee2, Melissa C Larson2, Paul J Hampel3, Timothy G Call3, Wei Ding3, Saad S Kenderian3, Jose F Leis4, Asher A Chanan-Khan5, Michael J Conte3, Deborah Bowen3, Susan M Schwager3, Susan L Slager2, Curtis A Hanson6, Neil E Kay3, Tait D Shanafelt7.   

Abstract

Mesh:

Year:  2018        PMID: 29419435      PMCID: PMC6058787          DOI: 10.3324/haematol.2017.183194

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  24 in total

1.  Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.

Authors:  J Moreira; K G Rabe; J R Cerhan; N E Kay; J W Wilson; T G Call; J F Leis; D F Jelinek; S M Schwager; D A Bowen; C A Hanson; S L Slager; T D Shanafelt
Journal:  Leukemia       Date:  2012-07-11       Impact factor: 11.528

2.  Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population.

Authors:  T D Shanafelt; N E Kay; K G Rabe; T G Call; C S Zent; S M Schwager; J F Leis; D F Jelinek; S L Slager; C A Hanson
Journal:  Leukemia       Date:  2011-08-12       Impact factor: 11.528

3.  Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.

Authors:  Stefano Molica; Francesca R Mauro; Diana Giannarelli; Francesco Lauria; Agostino Cortelezzi; Maura Brugiatelli; Vincenzo Liso; Antonio Cuneo; Robin Foà
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

Review 4.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.

Authors:  T D Shanafelt; P Ghia; M C Lanasa; O Landgren; A C Rawstron
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

5.  Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Kari G Rabe; Neil E Kay; Clive S Zent; Diane F Jelinek; Megan S Reinalda; Susan M Schwager; Debbie A Bowen; Susan L Slager; Curtis A Hanson; Timothy G Call
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

6.  Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.

Authors:  Wolfgang Kern; Ulrike Bacher; Claudia Haferlach; Frank Dicker; Tamara Alpermann; Susanne Schnittger; Torsten Haferlach
Journal:  Br J Haematol       Date:  2012-01-09       Impact factor: 6.998

7.  CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Authors:  Tait D Shanafelt; Susan M Geyer; Nancy D Bone; Renee C Tschumper; Tom E Witzig; Greg S Nowakowski; Clive S Zent; Tim G Call; Betsy Laplant; Gordon W Dewald; Diane F Jelinek; Neil E Kay
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

8.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

9.  Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.

Authors:  Wei Xu; Jian-Yong Li; Yu-Jie Wu; Xin Cao; Lei Fan; Chun Qiao; Qiong Liu; Lin Yao; Kou-Rong Miao
Journal:  Leuk Res       Date:  2009-02-27       Impact factor: 3.156

10.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

Authors:  J L Binet; A Auquier; G Dighiero; C Chastang; H Piguet; J Goasguen; G Vaugier; G Potron; P Colona; F Oberling; M Thomas; G Tchernia; C Jacquillat; P Boivin; C Lesty; M T Duault; M Monconduit; S Belabbes; F Gremy
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

View more
  6 in total

1.  Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index.

Authors:  Geffen Kleinstern; Daniel R O'Brien; Xing Li; Shulan Tian; Brian F Kabat; Kari G Rabe; Aaron D Norman; Huihuang Yan; Celine M Vachon; Nicholas J Boddicker; Timothy G Call; Sameer A Parikh; Laura Bruins; Cecilia Bonolo de Campos; Jose F Leis; Tait D Shanafelt; Wei Ding; James R Cerhan; Neil E Kay; Susan L Slager; Esteban Braggio
Journal:  Am J Hematol       Date:  2020-05-07       Impact factor: 10.047

2.  Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

Authors:  Paul J Hampel; Wei Ding; Timothy G Call; Kari G Rabe; Saad S Kenderian; Thomas E Witzig; Eli Muchtar; Jose F Leis; Asher A Chanan-Khan; Amber B Koehler; Amie L Fonder; Susan M Schwager; Susan L Slager; Tait D Shanafelt; Neil E Kay; Sameer A Parikh
Journal:  Leuk Lymphoma       Date:  2019-04-24

3.  Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.

Authors:  Susan L Slager; Mark C Lanasa; Gerald E Marti; Sara J Achenbach; Nicola J Camp; Fatima Abbasi; Neil E Kay; Celine M Vachon; James R Cerhan; James B Johnston; Timothy G Call; Kari G Rabe; Geffen Kleinstern; Nicholas J Boddicker; Aaron D Norman; Sameer A Parikh; Jose F Leis; Versha Banerji; Danielle M Brander; Martha Glenn; Alessandra Ferrajoli; Karen Curtin; Esteban Braggio; Tait D Shanafelt; Mary L McMaster; J Brice Weinberg; Curtis A Hanson; Neil E Caporaso
Journal:  Blood       Date:  2021-04-15       Impact factor: 22.113

4.  Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis.

Authors:  In Young Yoo; Sung Hoan Bang; Dae Jin Lim; Seok Jin Kim; Kyunga Kim; Hee Jin Kim; Sun-Hee Kim; Duck Cho
Journal:  Ann Lab Med       Date:  2020-09       Impact factor: 3.464

Review 5.  Chronic lymphocytic leukemia treatment algorithm 2018.

Authors:  Sameer A Parikh
Journal:  Blood Cancer J       Date:  2018-10-03       Impact factor: 11.037

6.  Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort.

Authors:  Maxine Je Lamb; Alexandra Smith; Daniel Painter; Eleanor Kane; Timothy Bagguley; Robert Newton; Debra Howell; Gordon Cook; Ruth de Tute; Andrew Rawstron; Russell Patmore; Eve Roman
Journal:  BMJ Open       Date:  2021-02-22       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.